Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer - Dieli, F; Vermijlen, D; Fulfaro, F; Caccamo, N; Meraviglina, S; Cicero, G (Cancer Res, 2007)